Letter to the Editor

This letter explores a provider type that is part of the solution to the psychiatric shortage: psychiatric pharmacists.

Tendler et al argue that, in considering transcranial magnetic stimulation (TMS) treatment, providers should refer to recent guidelines and literature reports instead of universally excluding patients based on outdated,...

In this letter to the editor, Jun Maruta, PhD, and colleagues comment on a case report previously published in the PCC.

Anil K. Bachu, MD, responds to Maruta and colleagues regarding a case report previously published in the PCC.

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.